PHC Holdings Co. Ltd. has decided that Kyoko Deguchi will be appointed as the company's representative director and president on April 1, 2024. Masatsugu Miyazaki will step down from his duties as Representative director and president on March 31, and will continue to serve as a director until the general meeting of shareholders to be held in June.

Mr. Deguchi, who is currently an independent director of the Company, has over 20 years of experience in the healthcare and chemical industries, and has previously served as head of the Japanese subsidiary of various global healthcare companies, including Janssen Pharmaceuticals, Stryker, and AbbVie. He has held senior positions in finance, marketing, etc. Currently, he is involved in management as the vice director of rehabilitation orthopedics, and has experience as an outside director at multiple listed and unlisted companies, including T-Gaia Co.

Ltd. and Heartseed Co. Ltd.